Surveillance for invasive pulmonary aspergillosis in critically ill patients with COVID-19
B. Er (Ankara, Turkey), A. Er (Ankara, Turkey), D. Gulmez Kivanc (Ankara, Turkey), T. Sahin (Ankara, Turkey), B. Halacli (Ankara, Turkey), G. Durhan (Ankara, Turkey), E. Ortac Ersoy (Ankara, Turkey), G. Hazirolan (Ankara, Turkey), A. Alp (Ankara, Turkey), G. Metan (Ankara, Turkey), Z. Saribas (Ankara, Turkey), S. Arikan-Akdagli (Ankara, Turkey), S. Akinci (Ankara, Turkey), M. Ariyurek (Ankara, Turkey), A. Topeli (Ankara, Turkey), O. Uzun (Ankara, Turkey)
Source: Virtual Congress 2021 – Fungi, viruses, parasites and the immunocompromised
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Er (Ankara, Turkey), A. Er (Ankara, Turkey), D. Gulmez Kivanc (Ankara, Turkey), T. Sahin (Ankara, Turkey), B. Halacli (Ankara, Turkey), G. Durhan (Ankara, Turkey), E. Ortac Ersoy (Ankara, Turkey), G. Hazirolan (Ankara, Turkey), A. Alp (Ankara, Turkey), G. Metan (Ankara, Turkey), Z. Saribas (Ankara, Turkey), S. Arikan-Akdagli (Ankara, Turkey), S. Akinci (Ankara, Turkey), M. Ariyurek (Ankara, Turkey), A. Topeli (Ankara, Turkey), O. Uzun (Ankara, Turkey). Surveillance for invasive pulmonary aspergillosis in critically ill patients with COVID-19. 1884
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: